Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votesGovInfo API
Floor speeches, reports, bill textFederal Election Commission (FEC)
Campaign financeVoteView (UCLA)
Ideology scores (DW-NOMINATE)GovTrack.us
Misconduct data (CC0)U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

S3014Referred to Committee

Ensuring Timely Access to Generics Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-10-16
Introduced
2
Cosponsors
S
ⓘ
Type

Sponsor

Jeanne Shaheen
Jeanne Shaheen
Democrat · NH · Senator
Votes with party: 47.2% (318 recorded votes)

Full profile: /officials/S001181

Source: Congress.gov · FEC

Cosponsors (2)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • Susan M. Collins (R-ME)Original· 2025-10-16
  • Tammy Baldwin (D-WI)· 2025-10-21

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

2025-10-16

Source: Congress.gov

Committee Activity

Currently in

  • Senate Committee on Health, Education, Labor, and PensionsReferred To · 2025-10-16

Previously

  • Health, Education, Labor, and Pensions CommitteeReferred To · 2025-10-16

Plain-English Summary

The legislation would speed up the process for generic drug manufacturers to bring cheaper alternative versions of brand-name medications to the market, potentially reducing wait times from years to months. By streamlining FDA approval procedures and reducing regulatory barriers, the bill aims to help patients and insurance companies save money on prescription drugs while giving generic manufacturers a faster path to compete. The changes would primarily affect pharmaceutical companies, the FDA, patients who rely on affordable medications, and health insurers.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • SRES754A resolution reaffirming congressional support for the Taiwan Relations Act and longstanding bipartisan Taiwan policy.
    Referred to Committee · 2026-05-21
  • S4617A bill to strengthen transparency over efforts by the Department of the Treasury to use the Exchange Stabilization Fund to aid foreign countries without prior notification to Congress.
    Referred to Committee · 2026-05-21
  • S4614Stars and Stripes Editorial Independence Act of 2026
    Referred to Committee · 2026-05-20
  • S4612SCREEN for Type 1 Diabetes Act of 2026
    Referred to Committee · 2026-05-20